CytRx Receives NASDAQ Extension – MarketWatch (press release)
|
CytRx Receives NASDAQ Extension
MarketWatch (press release) LOS ANGELES, Apr 23, 2012 (BUSINESS WIRE) — CytRx Corporation (UTD:CYTR) , a biopharmaceutical company specializing in oncology, today announced that it has received a favorable ruling from the NASDAQ Hearings Panel (the "Panel"), whereby the Panel … |
